Sortilin in biliary epithelial cells promotes ductular reaction and fibrosis during cholestatic injury.

Cholestatic liver injury Leukemia inhibitory factor receptor Sortilin ductular reaction fibrosis

Journal

The American journal of pathology
ISSN: 1525-2191
Titre abrégé: Am J Pathol
Pays: United States
ID NLM: 0370502

Informations de publication

Date de publication:
15 Mar 2024
Historique:
received: 11 09 2023
revised: 03 01 2024
accepted: 29 01 2024
medline: 18 3 2024
pubmed: 18 3 2024
entrez: 17 3 2024
Statut: aheadofprint

Résumé

Cholestatic injuries are accompanied by a ductular reaction, initiated by proliferation and activation of biliary epithelial cells (BEC), leading to fibrosis. Sortilin (Sort1) facilitates IL-6 secretion and leukemia inhibitory factor (LIF) signaling. This study investigated the interplay between sortilin, IL-6 and LIF in cholestatic injury-induced ductular reaction, morphogenesis of new ducts and fibrosis. Cholestatic injury was induced by bile duct ligation (BDL) in WT and Sort1

Identifiants

pubmed: 38493927
pii: S0002-9440(24)00087-7
doi: 10.1016/j.ajpath.2024.01.023
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Einav Hubel (E)

The Research Center for Digestive Tract and Liver Diseases, Tel-Aviv Sourasky Medical Center and the Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Anat Neuman (A)

The Research Center for Digestive Tract and Liver Diseases, Tel-Aviv Sourasky Medical Center and the Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Sigal Fishman (S)

The Research Center for Digestive Tract and Liver Diseases, Tel-Aviv Sourasky Medical Center and the Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Ortal Schaffer (O)

Department of Pediatric Surgery, Assaf Harofe Hospital, Tzrifin, Israel.

Noam Erez (N)

The Research Center for Digestive Tract and Liver Diseases, Tel-Aviv Sourasky Medical Center and the Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Bander Abu Shrkihe (BA)

The Research Center for Digestive Tract and Liver Diseases, Tel-Aviv Sourasky Medical Center and the Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Yuval Shteingard (Y)

Department of Pathology, Tel-Aviv Sourasky Medical Center.

Tamar Gross (T)

Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.

Oren Shibolet (O)

The Research Center for Digestive Tract and Liver Diseases, Tel-Aviv Sourasky Medical Center and the Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Chen Varol (C)

The Research Center for Digestive Tract and Liver Diseases, Tel-Aviv Sourasky Medical Center and the Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel; Department of Clinical Microbiology and Immunology, Faculty of Medicine, Tel Aviv University. Electronic address: chenv@tlvmc.gov.il.

Isabel Zvibel (I)

The Research Center for Digestive Tract and Liver Diseases, Tel-Aviv Sourasky Medical Center and the Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. Electronic address: isab@tlvmc.gov.il.

Classifications MeSH